-+ 0.00%
-+ 0.00%
-+ 0.00%
ARGENX, a global biopharmaceutical company headquartered in Amsterdam, the Netherlands, will acquire FORTE BIOSCIENCES in cash of $77 per share.
Share
Listen to the news
ARGENX, a global biopharmaceutical company headquartered in Amsterdam, the Netherlands, will acquire FORTE BIOSCIENCES in cash of $77 per share.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending